ISLE OF WIGHT DIABETIC FUND
Relief and treatment of persons suffering from diabetes and any other disease which is co-existent with or related to diabetes.Promotion of public education and research into the nature, causes, prevention and treatment of diabetes.Promoting the health and welfare of persons suffering from diabetes.Promoting education in the nature, causes, prevention and treatment of diabetes.
Financial health, per its FY2025 accounts
The accounts state that unrestricted funds carried forward were £776,490, exceeding the trustees' policy target of six months' unrestricted expenditure due to a shortage of suitable projects. The charity reported a net income of £6,375 for the year, with total incoming resources of £30,496 against charitable expenditure of £24,253.
What the accounts disclose
“It is the policy of the charity to maintain unrestricted funds, which are the free reserves of the charity, at a level which equates to approximately six months unrestricted expenditure.” — page 3
“The charity owns 100% of the issued share capital of The Isle of Wight Diabetic Fund Trading Company Limited, a company incorporated in England and Wales. The company trades in support of the Isle of Wight Diabetic Fund.” — page 15
Trustees
- PAUL ST JOHN JACOBSchair
- Dr VICTOR LAWRENCE
- ELIZABETH WHITTINGSTALL
- Rachel Flood
- Richard Knowles
- Stephanie Stanley
- TRACEY ELIZABETH PORTEOUS
- Terence Willey
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/03/2025 | £30k | £24k |
| 31/03/2024 | £109k | £30k |
| 31/03/2023 | £22k | £16k |
| 31/03/2022 | £38k | £18k |
| 31/03/2021 | £29k | £20k |
Common questions
Is ISLE OF WIGHT DIABETIC FUND financially healthy?
Per its FY2025 accounts: The accounts state that unrestricted funds carried forward were £776,490, exceeding the trustees' policy target of six months' unrestricted expenditure due to a shortage of suitable projects. The charity reported a net income of £6,375 for the year, with total incoming resources of £30,496 against charitable expenditure of £24,253. Its FY2025 accounts were independently examined.